Henry Schein Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, and ReDent Nova, a Tel Aviv-based dental company, have reached a new global agreement.
Henry Schein Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, and ReDent Nova, a Tel Aviv-based dental company, have reached a new global agreement. Under the new agreement, Henry Schein will serve as exclusive distributor of ReDent Nova products in Germany and the Netherlands. Additionally, the two companies will cooperate on servicing customers who have previously purchased ReDent Nova products from Henry Schein in other countries around the world.
"We are very pleased to have reached this exclusive agreement and look forward to offering the ReDent Nova product line to our dental customers in Germany and the Netherlands," said Jim Breslawksi, President and Chief Operating Officer, Henry Schein. "ReDent Nova's SAF (Self Adjusting File) is a unique product in the 'Minimally Invasive Endodontic' category, and we are delighted to add it to our broad and growing offering of products within this market segment in these two countries."
About ReDent Nova Ltd.?
ReDent Nova Ltd. is a dental technology company that develops designs, manufactures and markets innovative dental devices in the field of Minimally Invasive Endodontics. The company's flagship product is the SAF (Self Adjusting File), a device that shapes, cleans and disinfects the root canals during root canal treatment. In one step, this new process provides better performance and superior results while preserving the original anatomy of the root canal. Use of the SAF system dramatically reduces file separation and prevents micro cracks which are the main cause of vertical root fractures.
Supporting the growing trend for evidence-based medicine, ReDent Nova, based in Israel, works closely with world renowned key opinion leaders in the field of endodontology to conduct and publish extensive peer reviewed pre-clinical and clinical trials.
About Henry Schein, Inc. ?
Henry Schein, Inc. (NASDAQ: HSIC) is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs nearly 15,000 Team Schein Members and serves approximately 775,000 customers.